Key result
Targeted multidrug regimens achieve ~73% clinical cure in Nocardia infective endocarditis.
Why the study?
Data on infective endocarditis caused by Nocardia species are scarce in the literature, and a review systematically summarizing all available evidence on its epidemiology, microbiology, clinical characteristics, treatment, and outcomes was lacking.
Systematic Review (n=26)
This systematic review characterizes Nocardia infective endocarditis as a rare infection predominantly affecting the aortic valve and prosthetic valves (30.8%), carrying a high mortality rate of 26.9% despite antimicrobial treatment.
Answers are grounded in this paper and cite their sources.
High mortality persists despite standard regimens in Nocardia endocarditis; extends sparse evidence for this rare infection.
Nocardiosis, is a potentially life-threatening disease, especially in immunocompromised individuals where it manifests as a disseminated disease. Infective Endocarditis (IE) is a rare disease with significant morbidity and mortality. Importantly, even though there are scarce data of IE by Nocardia spp. in the literature, a review adequately summarizing systematically all available evidence on the topic is lacking. The aim of this study was to systematically review all cases of IE by Nocardia spp. and describe the epidemiology, microbiology, clinical characteristics, treatment and outcomes of this infection. A systematic review of PubMed, Scopus and Cochrane library (through 7 December 2021) for studies providing epidemiological, clinical, microbiological as well as treatment data and outcomes of patients with IE by Nocardia spp. was performed. A total of 25 studies providing data for 26 patients were included. A prosthetic valve was present in 30.8%, while the most common microorganism was N. asteroides. Aortic valve was the most commonly infected intracardiac site, followed by the mitral valve. Diagnosis was most commonly performed with transthoracic echocardiography, while the diagnosis was made at autopsy in 11.5%. Co-trimoxazole, aminoglycosides and carbapenems were the most commonly used antimicrobials. Clinical cure was noted in 73.1%, while mortality was 26.9%. This systematic review thoroughly describes IE by Nocardia and provides information on epidemiology, clinical presentation, treatment and outcomes.
No takes yet. Share an insight, caveat, or question.
Velidakis et al. (2022) conducted a systematic review in Infective endocarditis by Nocardia species (n=26). Antimicrobial therapy (most commonly co-trimoxazole, aminoglycosides, and carbapenems) was evaluated on Clinical cure and mortality. Infective endocarditis by Nocardia spp. treated primarily with co-trimoxazole, aminoglycosides, and carbapenems resulted in a 73.1% clinical cure rate and 26.9% mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: